FANG Tong,GAO Hong.Clinical trial of low-dose whole body irradiation in the non_myeloablative hematopoietic stem cell transplantation[J].Chinese Journal of Radiological Medicine and Protection,2009,29(1):80-82
Clinical trial of low-dose whole body irradiation in the non_myeloablative hematopoietic stem cell transplantation
Received:June 02, 2008  
DOI:10.3760/cma.j.issn.0254-5098.2009.01.025
KeyWords:Hematopoietic stem cell transplantation  Non-myeloablative stem cell transplantation  pretreatment  Total body irradiation
FundProject:
Author NameAffiliationE-mail
FANG Tong Department of Radiation Oncology, Beijing Shijitan Hospital, Beijing 100038, China  
GAO Hong Department of Radiation Oncology, Beijing Shijitan Hospital, Beijing 100038, China gaohongdoctor@sina.com 
Hits: 2947
Download times: 2171
Abstract::
      Objective To observe the efficacy and acute toxicity in non-myeloablative low-dose tatal body irradiation. Methods From January 2006 to January 2008, 27 cases of hematopoietic stem cell transplantation patients received non_myeloablative pretreatment program involving low-dose whole body irradiation. Pretreatment program: the total dose of TBI was 2 Gy, once completely. According to primary disease, physical condition, age, organ function and HAL coincide situation, the patients received different chemotherapy, including FUL, CTX, Ara-C, melphalan and so on. To prevent the graft-versus-host disease (GVHD), CSA/MMF was used. Results Hematopoietic reconstruction: the peripheral blood WBC in all 27 cases reduced to (0.05-0.9)×109/L in 4 to 8 days, with the neutrophil count>0.5×109/L in 8 to 22 days (median+10.5 days), the platelet count> 30×109/L in 11 to 28 days (median+14.5 days). The transplant rate was 85.2% (23/27). The fever rate was 65% and the infection rate was 37%(10/27). Hemorrhagic cystitis,hepatic veno-occlusive disease (HVOD),and other complications did not occurred. 4 cases developed aGVHD (15%) and 5 cases developed cGVHD (19%) out of 27 cases. Follow-up 3 to 22 months, 21 cases are still alive(77.8%).Conclusion Pretreatment with low-dose whole body irradiation of non-myeloablative hematopoietic stem cell transplantation proved to be simple and safe with fewer complications and broad indications. Program of TBI with total dose of 2 Gy (once completely) is a safe, less toxic and effective method. It could achieve the effectiveness of immune suppression.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9069470  On-line:0

v
Scan QR Code
&et=3C06DB566315F8DCCDD2E79C7A42E415262F408E69FCA417BE5753FF0C4EB420406C962842E09E4B860CC68A3D716C6B7247F383F99F2C457A20CB00A904A2D8BBB0472156C9C52A69217C72554CDD620D78FA8691768B74280FFE4F3E28197E6D3A6EAAD9F5270E6B953104A545084E64520B018B61348B&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=DE12191FBD62783C&aid=548B7C3B252A73CA81604CA50A6EB795&vid=&iid=CA4FD0336C81A37A&sid=E203FB1A272C9DD2&eid=0D0D661F0B316AD5&fileno=20090125&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="DE12191FBD62783C"; var my_aid="548B7C3B252A73CA81604CA50A6EB795";